Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Unions blast ‘negative consequences’ for Sweden of a Pfizer-AZ deal

Say proposed takeover posed an imminent risk to country's life science sector

- PMLiVE

Eisai resubmits Fycompa to G-BA for pricing assessment

But German distribution of epilepsy drug remains on hold until reimbursement settled

- PMLiVE

Abbott strikes $3.3bn Latin America generics deal

Boosts portfolio in region with acquisition of CFR Pharmaceuticals

- PMLiVE

AstraZeneca rejects ‘final offer’ from Pfizer

And US pharma company rules out hostile takeover

Novartis building

FDA rejects Novartis’ breakthrough heart failure drug

Regulator wants more data on serelaxin

- PMLiVE

This month in 1876: Creation of Eli Lilly & Company

How a visit to the Good Samaritan Drugstore put an Indiana teenager on the road to pharma success

- PMLiVE

Invokana set for NICE recommendation

Janssen drug will provide another treatment option in diabetes

- PMLiVE

FDA unveils new biosimilars guidance

Will clarify route to market for copies of biological drugs

Bristol-Myers Squibb (BMS) building

BMS’ nivolumab gets breakthrough status

But shares fall on concerns over new trial data

- PMLiVE

80% of doctors in China use a smartphone

Study suggests pharma marketers must tailor their approach to the technology

Biogen Idec names VP for value-based medicine

Richard Rudick joins from Cleveland Clinic

- PMLiVE

McCann wins Reckitt Benckiser account

Agency regains place on the healthcare company’s roster

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links